Sections
Shows
Events
Zydus Cadila's COVID-19 vaccine passes Phase I safety trials; Phase II to test efficiency begins 6 August
Zydus Cadila begins human trials of COVID-19 vaccine candidate ZyCoV-D in 1,000 volunteers
